1 – 20 of 33
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Recurrent implantation failure and inflammatory markers in serum and follicle fluid of women undergoing assisted reproduction
(
- Contribution to journal › Article
-
Mark
Anti-Müllerian hormone and fertility in women after childhood cancer treatment : Association with current infertility risk classifications
(
- Contribution to journal › Article
-
Mark
Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first IVF/ICSI treatment
2024) In Fertility and Sterility(
- Contribution to journal › Article
-
Mark
Prevalence of adenomyosis features in women scheduled for assisted reproductive treatment, using the Morphological Uterus Sonographic Assessment group definitions
2024) In Acta Obstetricia et Gynecologica Scandinavica(
- Contribution to journal › Article
- 2023
-
Mark
Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency
(
- Contribution to journal › Article
-
Mark
Prevalence of adenomyosis, as diagnosed at transvaginal ultrasound, in infertile women scheduled for their first assisted reproductive treatment
2023) World congress on Ultrasound in Obstetrics and gynecology, Seoul, October 2024 In Ultrasound in Obstetrics & Gynecology 62(S1). p.270-270(
- Contribution to journal › Published meeting abstract
- 2022
-
Mark
Prevalence of endometrioma and deep infiltrating endometriosis at transvaginal ultrasound examination of subfertile women undergoing assisted reproductive treatment
(
- Contribution to journal › Article
- 2021
-
Mark
Premature ovarian failure after childhood cancer and risk of metabolic syndrome : A cross-sectional analysis
(
- Contribution to journal › Article
-
Mark
RUBIC (ReproUnion Biobank and Infertility Cohort) : A binational clinical foundation to study risk factors, life course, and treatment of infertility and infertility-related morbidity
(
- Contribution to journal › Article
- 2019
-
Mark
Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment
(
- Contribution to journal › Article
-
Mark
Gonadotropin receptor variants are linked to cumulative live birth rate after in vitro fertilization
(
- Contribution to journal › Article
-
Mark
Interaction between serum levels of Anti-Mullerian Hormone and the degree of sperm DNA fragmentation measured by sperm chromatin structure assay can be a predictor for the outcome of standard in vitro fertilization
(
- Contribution to journal › Article
-
Mark
The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation
(
- Contribution to journal › Article
- 2018
-
Mark
Treatment efficacy for idiopathic recurrent pregnancy loss - a systematic review and meta-analyses
(
- Contribution to journal › Article
-
Mark
Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-müllerian hormone is modest
(
- Contribution to journal › Article
- 2017
-
Mark
Prematurity and neonatal outcome including congenital malformations after maternal malignancy within six months prior to or during pregnancy
(
- Contribution to journal › Article
-
Mark
Congenital malformations in offspring of women with a history of malignancy
(
- Contribution to journal › Article
- 2016
-
Mark
Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization.
(
- Contribution to journal › Article
-
Mark
Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable
(
- Contribution to journal › Article
-
Mark
Characteristics of the Offspring of Women with a History of Malignancy, Excluding Congenital Malformations
(
- Contribution to journal › Article